Compass Pathways (ADR)
Develops COMP360, an investigational psilocybin treatment with psychological support.
$13.79
After-hours close+0.08 (+0.56%)
At close$13.72(−6.32%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.36 | — | — |
| Aug 2026 | −$0.46 | −$1.88 | −308.7% |
| May 2026 | −$0.45 | −$0.30 | +33.3% |
| Mar 2026 | −$0.41 | −$0.59 | −43.9% |
| Nov 2025 | −$0.40 | −$0.38 | +5.0% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | −$0.36 | — | — | — | — | — |
| Aug 5, 2026 | −$0.46 | −$1.88 | −308.7% | — | — | — |
| May 13, 2026 | −$0.45 | −$0.30 | +33.3% | — | — | — |
| Mar 24, 2026 | −$0.41 | −$0.59 | −43.9% | — | — | — |
| Nov 4, 2025 | −$0.40 | −$0.38 | +5.0% | — | — | — |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | ||||||
| Jul 31, 2025 | ||||||
| May 8, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Oct 31, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 29, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 11, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 10, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 11, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 9, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Sep 21, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||